A 58-year-old gentleman admitted to the intensive care unit (ICU) with Pneumocystis jirovecii pneumonia and advanced HIV developed a potentially lethal hyperkalaemia secondary to his antibiotic treatment. The mechanism and treatment are described.
DockerillDHBreenRLipmanMMillerRF. British HIV Association and British Infection Association Guidelines for the Treatment of Opportunistic Infection in HIV-seropositive Individuals 2011. HIV Med2011;12: 25–42.
2.
VelazquezHPerazellaMAWrightFSEllisonDH. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med1993;119: 296–301.
3.
GreenbergSReiserIWChouSYPorushJG. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med1993;119: 291–95.
4.
PerazellaMA. Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management. Drug Safety2000;22: 227–36.
5.
MoriHKurodaYImamuraS. Hyponatraemia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamthoxazole. Inter Med2003;42: 665–69.
6.
MohanSJaitlyMPogueVAChengJT. Influence of concomitant prednisolone on trimethoprim-associated hyperkalaemia. J Antimicrob Chemoth2009;64: 850–52.
7.
AlappanRPerazellaMABullerGK. Hyperkaemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Ann Intern Med1996;124: 316–20.
8.
KalinMFPoretskyLSeresDSZumoffB. Hyporenemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am J Med1987;82: 1035–38.
9.
CarameloCBelloERuizE. Hyperkalemia in patients infected with the human immunodeficiency virus: involvement of a systemic mechanism. Kidney Int1999;56: 198–205.
10.
SellmeyerDGrunfieldC. Endocrine and metabolic disturbance in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev1996;17: 518–32.
11.
JapiassuAMAmancioRTMesquitaEC. Sepsis is a major determinant in critically ill HIV/AIDS patients. Crit Care2010;14: R152.
12.
RapakaVDanielVSindhaghattaV. Septic shock due to Pneumocystis pneumonia in HIV infected patients – is the virulence of Pneumocystis jirovecii changing?Internet J Pulm Med2012;13. DOI:10.55580/2ca7.
13.
Health Protection Agency. HIV in the United Kingdom: 2010 report. Health Protection Report.London:HPA2010;4: 6.
14.
DicksonSJBatsonSCopasAJ. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax2007;62: 964–68.
15.
LeapeLLCullenDJClappMD. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA1999;282: 267–70.
16.
KimMMBarnatoAEAngusDC. The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med2010;170: 369–76.
